Navigation Links
DrugRisks Update: New Study Warns of Pradaxa Brain Bleeding
Date:5/21/2013

Chicago, IL (PRWEB) May 21, 2013

The prescriptin drug resource center DrugRisks.com is announcing new information on the site for patients taking the blood thinner Pradaxa. A recent study suggests patients taking the drug may be at more risk of death when suffering a head injury than those taking traditional anticoagulants*.

DrugRisks was created to improve the safety of patients taking popular prescription drugs by providing the latest warnings, recalls, studies and legal news. Visitors can see if others are experiencing similar side effects and decide if they need legal advice.

Health experts have disagreed over whether Pradaxa has higher risks of internal bleeding than traditional blood thinners. The FDA has stated the drug is as safe as warfarin**. However, the Institute for Safe Medication Practices recently warned that Pradaxa bleeding may be nearly 5 times as likely to result in death than bleeding from warfarin or Coumadin***.

The resource center has also added a study from the University of Illinois at Chicago suggesting the data used by the FDA may be flawed, and the risk for Pradaxa bleeding may be higher than expected****.

Now, DrugRisks has learned of a new study published this month in the Journal of Neurosurgery, showing that patients who suffer head trauma while taking Pradaxa are more likely to die of brain hemorrhage than those taking warfarin*.

Due to the number of patients who have filed a Pradaxa lawsuit alleging internal bleeding, cases have been consolidated to a special federal court in Illinois. The case is formally known as MDL No. 2385, IN RE: Pradaxa Product Liability Litigation, Southern District of Illinois.

Anyone affected by internal bleeding after taking Pradaxa is encouraged to speak with a lawyer about their legal options. Due to the specialized nature of federal drug injury cases, DrugRisks only recommends lawyers who have already handled Pradaxa lawsuits.

Visit http://www.DrugRisks.com today for more information on the research, side effects and litigation news related to Pradaxa and other drugs, or to speak with a lawyer.

*Journal of Neurosurgery, 5/1/13; thejns.org/doi/pdf/10.3171/2013.3.JNS12503
**FDA 11/2/12; http://www.fda.gov/Drugs/DrugSafety/ucm326580.htm
***Instutute for Safe Medication Practices, 1/9/13; ismp.org/quarterwatch/pdfs/2012Q2.pdf
****New England Journal of Medicine, 4/4/13; nejm.org/doi/full/10.1056/NEJMp1302834

Read the full story at http://www.prweb.com/releases/pradaxa-bleeding/lawsuit-study-brain/prweb10750534.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisks Adds Update from First Actos Trial of Patient Alleging Bladder Cancer
2. DrugRisks Adds New Pradaxa Study Alert As Lawsuits Increase
3. DrugRisks Center NuvaRing Lawsuit News: Drug Maker May Have Concealed Risks
4. DrugRisks Stryker Recall Update: Company Warns Investors as Patients Alleging Injury Ask to Send Lawsuits to Federal Court
5. DrugRisks Adds Study Showing Pradaxa Viral Infection Risk
6. DrugRisks Update: Doctor Testifies Actos Main Cause of Bladder Cancer in Trial
7. DrugRisks Legal Update: Jury to Decide Actos Cancer Trial This Week
8. DrugRisks Update: Federal Court Schedules First Mirena Lawsuit Hearing
9. DrugRisks Adds Update From Court Ordering Mediation of Stryker Hip Lawsuits
10. DrugRisks News Update: Bayer Loses Yaz Patent as Blood Clot Settlements Continue
11. DrugRisks Update: Use of NuvaRing Drops Amid Injury Allegations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2017)... MA (PRWEB) , ... June 20, 2017 , ... Kenneth ... International AIDS Society (JIAS). , Dr. Mayer, who joined the JIAS Editorial Board ... is the founding Medical Research Director of Fenway Health and Co-Chair of ...
(Date:6/20/2017)... (PRWEB) , ... June 20, 2017 , ... HOUSTON – ... new website and a host of new options for today’s modern senior. Brazos ... maintain the active, independent lifestyle they love while offering them the services to support ...
(Date:6/20/2017)... ... June 20, 2017 , ... ... content solutions for the enterprise, is proud to announce Touchpoints integrations. ... ticketing systems, company websites, and more to provide a seamless customer experience. , ...
(Date:6/20/2017)... ... June 20, 2017 , ... ... in Cincinnati, OH for leading-edge care, whether or not they have a ... Using the BIOLASE WaterLase® iPlus™ laser, she targets bacteria and damaged tissue without ...
(Date:6/20/2017)... ... ... With certifications and experience that puts them at the top of the ... are currently accepting new patients at their practice for these custom clear aligners. These ... is why they offer the latest in modern dental techniques to ensure that all ...
Breaking Medicine News(10 mins):
(Date:5/30/2017)... , May 30, 2017 Therapix Biosciences ... Company specializing in the development of cannabinoid-based drugs, ... a company overview at three upcoming scientific and ... Annual LD Micro Invitational: ... Date:                     ...
(Date:5/26/2017)... 2017  In response to the opioid epidemic in ... is working with Pfizer to make up to 1 ... to community health centers, free and charitable clinics, public ... "Pfizer has a long-standing commitment to improving health ... safety through educational activities," said Caroline Roan , ...
(Date:5/22/2017)... , May 22, 2017  Lilac Corp, ... Gene-Eden-VIR/Novirin, announces the launch of a new ... the results of a clinical study that showed ... treatment with Gene-Eden-VIR/Novirin in individuals suffering from HPV ... note that there are no other treatments that ...
Breaking Medicine Technology: